code blue halves presentation
TRANSCRIPT
![Page 1: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/1.jpg)
![Page 2: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/2.jpg)
Antonin Boyao Sarah Alejandra
![Page 3: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/3.jpg)
B I O M E D I C A LE N G I N E E R I N G CMU
BioMed
CUDenver
![Page 4: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/4.jpg)
![Page 5: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/5.jpg)
![Page 6: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/6.jpg)
- Invasive
+ Life-prolonging
+ Better QoL
![Page 7: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/7.jpg)
- Invasive
+ Life-prolonging
+ Better QoL
![Page 8: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/8.jpg)
Left VentricularAssist Device
Destination Therapy
![Page 9: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/9.jpg)
Major decision
![Page 10: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/10.jpg)
Major decisionMajor decisionMajor decisionMajor decisionMajor decisionMajor decisionMajor decisionMajor decisionMajor decisionMajor decisionMajor decisionMajor decisionMajor decision
![Page 11: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/11.jpg)
Major decision
![Page 12: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/12.jpg)
Industry-sponsored
Fails IPDASInterventionbiased
But current decision aids…
![Page 13: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/13.jpg)
![Page 14: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/14.jpg)
Long IncompleteBoring
Decision aid video is…
![Page 15: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/15.jpg)
Not innovative
Video poorly suitedContinuity issues
SYNTHETICINTERVIEW
Feels unnatural
![Page 16: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/16.jpg)
Continual updates
RESHOOTINGEXISTING VIDEO
IP concernsGrant overlap
![Page 17: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/17.jpg)
Our proposal
![Page 18: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/18.jpg)
Hypertext FAQ
Patient responses
Searchable videos
Patient Prognostic Info
![Page 19: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/19.jpg)
Consultation with doctor
User sign-in
Text or
video?
Text-based summary of
LVAD
Text doc with links
Patient data &
doc eval.
myCORA patient
database
User responses
User leaves app
myCORA personal health
info
Landing page
Clip of general
LVAD infoVideo
reference
“I understand what an LVAD is. Take me
to my personal health info.”
B
A
A
Text
Video
B
KEY:Orange: Hypertext FAQGreen: Searchable videosBlue: Patient Prognostic InfoPurple: Patient responsesPink: Client’s existing infrastructure
First-time flowOnly available later
![Page 20: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/20.jpg)
Consultation with doctor
User sign-in
Text or
video?
Text-based summary of
LVAD
Text doc with links
Patient data & doc eval.
myCORA patient databas
e
User responses
User leaves app
myCORA personal health
info
Landing page
Clip of general
LVAD infoVideo
reference
“I understand what an LVAD is. Take me
to my personal health info.”
B
A
A
Text
Video
B
KEY:Orange: Hypertext FAQGreen: Searchable videosBlue: Patient Prognostic InfoPurple: Patient responsesPink: Client’s existing infrastructure
First-time flowOnly available later
![Page 21: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/21.jpg)
Consultation with doctor
User sign-in
Text or
video?
Text-based summary of
LVAD
Text doc with links
Patient data &
doc eval.
myCORA patient
database
User responses
User leaves app
myCORA personal
health info
Landing page
Clip of general
LVAD infoVideo
reference
“I understand what an LVAD is. Take me to my personal health
info.”
B
A
A
Text
Video
B
KEY:Orange: Hypertext FAQGreen: Searchable videosBlue: Patient Prognostic InfoPurple: Patient responsesPink: Client’s existing infrastructure
First-time flowOnly available later
![Page 22: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/22.jpg)
Consultation with doctor
User sign-in
Text or
video?
Text-based summary of
LVAD
Text doc with links
Patient data &
doc eval.
myCORA patient
database
User responses
User leaves app
myCORA personal health
info
Landing page
Clip of general
LVAD infoVideo
reference
“I understand what an LVAD is. Take me
to my personal health info.”
B
A
A
Text
Video
B
KEY:Orange: Hypertext FAQGreen: Searchable videosBlue: Patient Prognostic InfoPurple: Patient responsesPink: Client’s existing infrastructure
First-time flowOnly available later
![Page 23: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/23.jpg)
Consultation with doctor
User sign-in
Text or
video?
Text-based summary of
LVAD
Text doc with links
Patient data &
doc eval.
myCORA patient
database
User responses
User leaves app
myCORA personal health
info
Landing page
Clip of general
LVAD infoVideo
reference
“I understand what an LVAD is. Take me
to my personal health info.”
B
A
A
Text
Video
B
KEY:Orange: Hypertext FAQGreen: Searchable videosBlue: Patient Prognostic InfoPurple: Patient responsesPink: Client’s existing infrastructure
First-time flowOnly available later
![Page 24: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/24.jpg)
Consultation with doctor
User sign-in
Text or
video?
Text-based summary of
LVAD
Text doc with links
Patient data &
doc eval.
myCORA patient
database
User responses
User leaves app
myCORA personal health
info
Landing page
Clip of general
LVAD infoVideo
reference
“I understand what an LVAD is. Take me
to my personal health info.”
B
A
A
Text
Video
B
KEY:Orange: Hypertext FAQGreen: Searchable videosBlue: Patient Prognostic InfoPurple: Patient responsesPink: Client’s existing infrastructure
First-time flowOnly available later
![Page 25: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/25.jpg)
SPECIALCONSIDERATIONS
![Page 26: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/26.jpg)
SPECIALCONSIDERATIONS
Gentler colors
Clearly labelled buttons
Easy to read
Consistent design
![Page 27: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/27.jpg)
![Page 28: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/28.jpg)
What should I ask?
![Page 29: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/29.jpg)
![Page 30: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/30.jpg)
![Page 31: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/31.jpg)
![Page 32: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/32.jpg)
![Page 33: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/33.jpg)
![Page 34: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/34.jpg)
Client enrolls patients
Test with target age
range
New testing protocol
Imperfect testing
methods
USERTESTING
![Page 35: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/35.jpg)
MEASURES OF
SUCCESS
Spoofed patient
prognoses
Event risk
(inverted)
% LVAD acceptance
![Page 36: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/36.jpg)
Event risk
(inverted)
MEASURES OF
SUCCESS
High survival
% LVAD acceptance
![Page 37: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/37.jpg)
Event risk
(inverted)
MEASURES OF
SUCCESS
Low survival
% LVAD acceptance
![Page 38: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/38.jpg)
Event risk
(inverted)
% LVAD acceptance
MEASURES OF
SUCCESS
High survival, high
risk
![Page 39: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/39.jpg)
Event risk
(inverted)
% LVAD acceptance
MEASURES OF
SUCCESS
![Page 40: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/40.jpg)
Week 9 10 11 12 13 14 15 16
Data
Art
Programming
Production
Presentation Halves Softs Finals
KEY:Orange: Hypertext FAQGreen: Searchable videosBlue: Patient Prognostic InfoPurple: Patient responsesPink: Presentation
![Page 41: Code Blue Halves Presentation](https://reader034.vdocuments.mx/reader034/viewer/2022052418/58ed02bb1a28ab4f368b4639/html5/thumbnails/41.jpg)
PROBLEMExisting LVAD decision aids are all industry-sponsored and biased.
SOLUTIONCreate a new, objective decision aid in the form of a web app.
HYPERTEXT FAQCommon questions for patients who do not know what to ask.
SEARCHABLE VIDEOSDirect search for patients who already know what they want to ask.
PATIENT RESPONSESDid the patient really understand everything that was shown?
PROGNOSTIC INFOPersonalized, relevant info; never been added to a decision aid before.
USER TESTINGDone in collaboration with client, using spoofed patient prognoses.
SUM
MAR
Y